Oncolys BioPharma Inc.

06/06/2023 | Press release | Distributed by Public on 06/06/2023 00:38

ASCO 2023 ANNOUNCEMENT: Encouraging Preliminary Data of OBP-301 with Pembrolizumab in refractory gastroesophageal adenocarcinoma